Catalyst Wire Dossier Catalyst Wire Dossier

MDV3100 (ASP9785)

enzalutamide · Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDV3100 (ASP9785), covering 2013-08-01 to 2013-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole [Phase 1]

See pricing